А. П. Ребров

3 та иш

V. I. Razumovsky Saratov State Medical University, Saratov

1. Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)

   E. I. Tarlovskaya, A. G. Arutyunov, А. О. Конради +97

   МақолаLong-Term Effects of COVID-19Kardiologiia20210 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.000346

2. The effectiveness of therapy and the quality of life of patients with rheumatoid arthritis depending on the baseline treatment adherence

   Н. М. Никитина, Elena V. Egorova, L.R. Bogdalova Bogdalova +2

   МақолаRheumatoid Arthritis Research and TherapiesRussian Journal of Preventive Medicine20230 иқтибос

   ABIABI:AkademIndex/openalex/2023.article.008556

3. Neuropathic component of pain, comorbidity and quality of life in rheumathoid arthritis: are there any relationships?

   Н. М. Никитина, Elena V. Egorova, L. R. Bogdalova +2

   МақолаPain Mechanisms and TreatmentsRussian Journal of Preventive Medicine20230 иқтибос

   ABIABI:AkademIndex/openalex/2023.article.011463